Methanex vs Dow: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Methanex Corporation (MEOH)

Q3 202629 Jun – 1 Sep 2026

▲2▼2

Methanex idles plants as gas shortages bite, but record profits cushion the blow

Titan plant in Trinidad idled indefinitely Methanex is shutting its Titan methanol plant in Trinidad for good because it could not secure a new natural gas contract. This removes 860,000 tonnes of yearly production, a real hit to future supply and earnings, though the plant is preserved for a possible restart.
This is a major new supply loss that directly reduces Methanex's production capacity and future revenue.
Record Q2 profit and cash flow Methanex reported record quarterly earnings: $198 million profit, $577 million adjusted EBITDA, and revenue up 75% to $1.4 billion. Strong methanol prices and record North American output let it repay debt and return cash to shareholders, a clear boost to the stock.
This shows the company's core business is generating huge profits and cash, which supports the share price.
New Zealand plants to close, gas entitlements sold Methanex will sell its New Zealand gas contracts and idle its plants there by early 2027 because domestic gas supply keeps falling. This removes another production region, tightening the company's overall output and adding to worries about long-term supply.
This is a fresh, significant loss of production capacity that further reduces Methanex's future supply.
Oil price spike lifts energy shares U.S.-Iran strikes pushed oil above $75 and energy stocks up nearly 4%, with Methanex jumping 6.2% in a single day. Higher oil prices make methanol more competitive as a fuel and chemical feedstock, but this boost is tied to volatile geopolitics and may not last.
It explains a sharp short-term price move and the link between oil prices and methanol demand.

July 202629 Jun – 1 Sep 2026

▲2▼2

Methanex idles plants as gas shortages bite, but record profits cushion the blow

Titan plant in Trinidad idled indefinitely Methanex is shutting its Titan methanol plant in Trinidad for good because it could not secure a new natural gas contract. This removes 860,000 tonnes of yearly production, a real hit to future supply and earnings, though the plant is preserved for a possible restart.
This is a major new supply loss that directly reduces Methanex's production capacity and future revenue.
Record Q2 profit and cash flow Methanex reported record quarterly earnings: $198 million profit, $577 million adjusted EBITDA, and revenue up 75% to $1.4 billion. Strong methanol prices and record North American output let it repay debt and return cash to shareholders, a clear boost to the stock.
This shows the company's core business is generating huge profits and cash, which supports the share price.
New Zealand plants to close, gas entitlements sold Methanex will sell its New Zealand gas contracts and idle its plants there by early 2027 because domestic gas supply keeps falling. This removes another production region, tightening the company's overall output and adding to worries about long-term supply.
This is a fresh, significant loss of production capacity that further reduces Methanex's future supply.
Oil price spike lifts energy shares U.S.-Iran strikes pushed oil above $75 and energy stocks up nearly 4%, with Methanex jumping 6.2% in a single day. Higher oil prices make methanol more competitive as a fuel and chemical feedstock, but this boost is tied to volatile geopolitics and may not last.
It explains a sharp short-term price move and the link between oil prices and methanol demand.

Latest29 Jun – 1 Sep 2026

▲2▼2

Methanex idles plants as gas shortages bite, but record profits cushion the blow

Titan plant in Trinidad idled indefinitely Methanex is shutting its Titan methanol plant in Trinidad for good because it could not secure a new natural gas contract. This removes 860,000 tonnes of yearly production, a real hit to future supply and earnings, though the plant is preserved for a possible restart.
This is a major new supply loss that directly reduces Methanex's production capacity and future revenue.
Record Q2 profit and cash flow Methanex reported record quarterly earnings: $198 million profit, $577 million adjusted EBITDA, and revenue up 75% to $1.4 billion. Strong methanol prices and record North American output let it repay debt and return cash to shareholders, a clear boost to the stock.
This shows the company's core business is generating huge profits and cash, which supports the share price.
New Zealand plants to close, gas entitlements sold Methanex will sell its New Zealand gas contracts and idle its plants there by early 2027 because domestic gas supply keeps falling. This removes another production region, tightening the company's overall output and adding to worries about long-term supply.
This is a fresh, significant loss of production capacity that further reduces Methanex's future supply.
Oil price spike lifts energy shares U.S.-Iran strikes pushed oil above $75 and energy stocks up nearly 4%, with Methanex jumping 6.2% in a single day. Higher oil prices make methanol more competitive as a fuel and chemical feedstock, but this boost is tied to volatile geopolitics and may not last.
It explains a sharp short-term price move and the link between oil prices and methanol demand.

Dow Inc (DOW)

Q3 202623 Jul – 21 Sep 2026

▼2

Dow cuts outlook, faces Canada tariffs, weighs Sadara sale

Canada tariffs hit Dow exports Canada's retaliatory tariffs on U.S. goods took effect September 8, hitting plastics and chemicals that include Dow products. This makes Dow's exports to Canada more expensive, likely reducing sales and pressuring profit.
New trade barrier directly affecting Dow's sales and pricing power.
Dow weighs selling Sadara stake Dow is reportedly considering selling its 35% stake in the $20 billion Sadara joint venture with Saudi Aramco. A sale could bring cash but forfeit future recovery upside, and the headline $20 billion is not the current value of Dow's stake.
Portfolio move with major cash and strategic implications for Dow's balance sheet.
Dow trims Q3 EBITDA outlook Dow cut its third-quarter EBITDA forecast to $1.5–1.6 billion, citing weaker polyethylene pricing in the Americas and soft construction and automotive demand. This signals near-term earnings pressure, though cost cuts and working-capital release offer some offset.
Direct reduction in expected earnings, a key driver of stock value.
Debt paydown prioritized over buybacks Dow will use excess cash to reduce debt and does not expect share buybacks in 2026, keeping the $0.35 dividend as the main shareholder return. This strengthens the balance sheet but removes a potential stock support, and the dividend is half its former level.
Capital allocation shift affects shareholder returns and financial risk.

August 202623 Jul – 21 Sep 2026

▼2

Dow cuts outlook, faces Canada tariffs, weighs Sadara sale

Canada tariffs hit Dow exports Canada's retaliatory tariffs on U.S. goods took effect September 8, hitting plastics and chemicals that include Dow products. This makes Dow's exports to Canada more expensive, likely reducing sales and pressuring profit.
New trade barrier directly affecting Dow's sales and pricing power.
Dow weighs selling Sadara stake Dow is reportedly considering selling its 35% stake in the $20 billion Sadara joint venture with Saudi Aramco. A sale could bring cash but forfeit future recovery upside, and the headline $20 billion is not the current value of Dow's stake.
Portfolio move with major cash and strategic implications for Dow's balance sheet.
Dow trims Q3 EBITDA outlook Dow cut its third-quarter EBITDA forecast to $1.5–1.6 billion, citing weaker polyethylene pricing in the Americas and soft construction and automotive demand. This signals near-term earnings pressure, though cost cuts and working-capital release offer some offset.
Direct reduction in expected earnings, a key driver of stock value.
Debt paydown prioritized over buybacks Dow will use excess cash to reduce debt and does not expect share buybacks in 2026, keeping the $0.35 dividend as the main shareholder return. This strengthens the balance sheet but removes a potential stock support, and the dividend is half its former level.
Capital allocation shift affects shareholder returns and financial risk.

Latest23 Jul – 21 Sep 2026

▼2

Dow cuts outlook, faces Canada tariffs, weighs Sadara sale

Canada tariffs hit Dow exports Canada's retaliatory tariffs on U.S. goods took effect September 8, hitting plastics and chemicals that include Dow products. This makes Dow's exports to Canada more expensive, likely reducing sales and pressuring profit.
New trade barrier directly affecting Dow's sales and pricing power.
Dow weighs selling Sadara stake Dow is reportedly considering selling its 35% stake in the $20 billion Sadara joint venture with Saudi Aramco. A sale could bring cash but forfeit future recovery upside, and the headline $20 billion is not the current value of Dow's stake.
Portfolio move with major cash and strategic implications for Dow's balance sheet.
Dow trims Q3 EBITDA outlook Dow cut its third-quarter EBITDA forecast to $1.5–1.6 billion, citing weaker polyethylene pricing in the Americas and soft construction and automotive demand. This signals near-term earnings pressure, though cost cuts and working-capital release offer some offset.
Direct reduction in expected earnings, a key driver of stock value.
Debt paydown prioritized over buybacks Dow will use excess cash to reduce debt and does not expect share buybacks in 2026, keeping the $0.35 dividend as the main shareholder return. This strengthens the balance sheet but removes a potential stock support, and the dividend is half its former level.
Capital allocation shift affects shareholder returns and financial risk.

Q2 202623 Jun – 3 Jul 2026

▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.
This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.
Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.
This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.
Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.
This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.
Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.
These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

June 202623 Jun – 3 Jul 2026

▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.
This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.
Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.
This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.
Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.
This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.
Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.
These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.

23 Jun – 3 Jul 2026

▼3▲1

Dow's rally fades as weak polyethylene prices and Alberta costs overshadow growth bets

RBC downgrade and price target cut RBC downgraded Dow to Sector Perform and slashed its price target to $28 from $51, warning that recent polyethylene price gains will fade and the Alberta project will strain cash flow. This directly lowers the market's expected value for Dow shares.
This is the single most direct negative driver of the period, resetting analyst expectations and the stock's perceived worth.
Polyethylene oversupply and weak pricing Analysts cut Dow's outlook because polyethylene prices are softening and the market is oversupplied, threatening cash flow and earnings recovery. Dow's commodity business remains under pressure, and the stock fell 8% as these concerns overshadowed positive news.
This is the core fundamental problem weighing on Dow's earnings and investor confidence, explaining why the stock dropped despite other positive announcements.
Chlorpyrifos lawsuit over Parkinson's link Dow faces a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson's disease, raising the risk of costly litigation, higher insurance premiums, and product restrictions. Until the total legal exposure is clear, this uncertainty weighs on investor sentiment.
This is a new legal and reputational risk that could lead to material costs and product restrictions, directly affecting Dow's future profitability.
Silicone and low-carbon growth investments Dow announced a $100 million investment to expand silicone production for electronics and thermal management, and a distribution deal for its Decarbia low-carbon products. These moves target higher-value, growing markets, but near-term they do little to offset weak commodity pricing.
These are the main positive strategic actions this period, showing Dow's effort to shift toward specialty and sustainable products, though their impact is longer-term.